BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26115010)

  • 1. Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases.
    Takagi T; Katagiri H; Kim Y; Suehara Y; Kubota D; Akaike K; Ishii M; Mukaihara K; Okubo T; Murata H; Takahashi M; Kaneko K; Saito T
    PLoS One; 2015; 10(6):e0129428. PubMed ID: 26115010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal metastases of unknown origin: a retrospective analysis of 29 cases.
    Jacobsen S; Stephensen SL; Paaske BP; Lie PG; Lausten GS
    Acta Orthop Belg; 1997 Mar; 63(1):15-22. PubMed ID: 9151454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin: a retrospective study.
    Katagiri H; Takahashi M; Inagaki J; Sugiura H; Ito S; Iwata H
    Cancer; 1999 Aug; 86(3):533-7. PubMed ID: 10430264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the management of patients with carcinoma of unknown primary.
    Deonarine P; Han S; Poon FW; de Wet C
    Scott Med J; 2013 Aug; 58(3):154-62. PubMed ID: 23960054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific survival rates for cancer of unknown primary according to location of metastases.
    Hemminki K; Riihimäki M; Sundquist K; Hemminki A
    Int J Cancer; 2013 Jul; 133(1):182-9. PubMed ID: 23233409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations for bone metastasis from an unknown primary.
    Destombe C; Botton E; Le Gal G; Roudaut A; Jousse-Joulin S; Devauchelle-Pensec V; Saraux A
    Joint Bone Spine; 2007 Jan; 74(1):85-9. PubMed ID: 17218141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent status of the diagnosis and treatment of bone metastasis in patients with advanced lung cancer].
    Eguchi K; Saijo N; Shinkai T; Sasaki Y; Tamura T; Sakurai M; Oyamada H; Terui K; Fukuma H; Beppu Y
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1696-703. PubMed ID: 3036014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?
    Hendriks LE; Smit EF; Vosse BA; Mellema WW; Heideman DA; Bootsma GP; Westenend M; Pitz C; de Vries GJ; Houben R; Grünberg K; Bendek M; Speel EJ; Dingemans AM
    Lung Cancer; 2014 Apr; 84(1):86-91. PubMed ID: 24529684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic work-up and outcome of cervical metastases from an unknown primary.
    Guntinas-Lichius O; Peter Klussmann J; Dinh S; Dinh M; Schmidt M; Semrau R; Mueller RP
    Acta Otolaryngol; 2006 May; 126(5):536-44. PubMed ID: 16698706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Survival Patterns of Patients with Bone Metastasis from Common Cancers in Thailand.
    Phanphaisarn A; Patumanond J; Settakorn J; Chaiyawat P; Klangjorhor J; Pruksakorn D
    Asian Pac J Cancer Prev; 2016; 17(9):4335-4340. PubMed ID: 27797240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
    Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
    Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
    Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features of pathologically confirmed metastatic bone tumors--a report of 390 cases].
    Xu DL; Zhang XT; Wang GH; Li FB; Hu JY
    Ai Zheng; 2005 Nov; 24(11):1404-7. PubMed ID: 16552972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solitary bone metastases of unknown origin.
    Ugras N; Yalcinkaya U; Akesen B; Kanat O
    Acta Orthop Belg; 2014 Mar; 80(1):139-43. PubMed ID: 24873099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy.
    Rougraff BT; Kneisl JS; Simon MA
    J Bone Joint Surg Am; 1993 Sep; 75(9):1276-81. PubMed ID: 8408149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of bone metastases from urological malignancies: an analysis of 70 cases.
    Toğral G; Arıkan M; Aktaş E; Öztürk R; Güven O; Eksioğlu F
    Acta Orthop Traumatol Turc; 2015; 49(6):634-40. PubMed ID: 26511690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of clinical problems associated with bone metastases from carcinoma from unknown primary sites.
    Hoshi M; Taguchi S; Hayakawa K; Ieguchi M; Nakamura H
    Arch Orthop Trauma Surg; 2011 Jan; 131(1):59-64. PubMed ID: 20411269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment for pathologic fracture.
    Wedin R
    Acta Orthop Scand Suppl; 2001 Jun; 72(302):2p., 1-29. PubMed ID: 11582636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma.
    Schapira DV; Jarrett AR
    Arch Intern Med; 1995 Oct; 155(19):2050-4. PubMed ID: 7575063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival After Distant Metastasis in Head and Neck Cancer.
    Wiegand S; Zimmermann A; Wilhelm T; Werner JA
    Anticancer Res; 2015 Oct; 35(10):5499-502. PubMed ID: 26408715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.